192 related articles for article (PubMed ID: 8168736)
1. [Prognostic factors in breast cancer].
Jonat W; Eidtmann H; Friedrichs K
Gynakologe; 1994 Feb; 27(1):37-44. PubMed ID: 8168736
[No Abstract] [Full Text] [Related]
2. [Prognostic factors in breast cancer and their consequences for therapeutic decisions].
Graeff H; Jänicke F
Chirurg; 1992 Jun; 63(6):461-8. PubMed ID: 1643982
[No Abstract] [Full Text] [Related]
3. [Value of steroid hormone receptors as prognostic factors in breast, ovarian and endometrial cancer].
von Minckwitz G; Kaufmann M
Gynakologe; 1993 Apr; 26(2):100-6. PubMed ID: 8508979
[No Abstract] [Full Text] [Related]
4. [Comparison of the estrogen and progesterone receptor content of primary breast cancers without skeletal or visceral metastasis with tumor marker MCA, CEA and CA 15-3 serum concentration at the time of surgery].
Seifert M; Wierrani F; Kubista E; Spona J
Gynakol Rundsch; 1991; 31 Suppl 2():397-8. PubMed ID: 1790992
[No Abstract] [Full Text] [Related]
5. [Initial results of the Project of the German Breast Cancer Study Group on "Breast saving therapy of the small breast cancer"].
Rauschecker HF; Gatzemeier W; Sauer R; Seegenschmiedt MH; Schauer A; Ummenhofer L; Sauerbrei W; Schmoor C; Schumacher M
Chirurg; 1992 Jun; 63(6):495-500. PubMed ID: 1643987
[TBL] [Abstract][Full Text] [Related]
6. [Cell receptors and proliferation markers in breast cancer].
Czerwenka KF; Schön HJ; Zeillinger R; Kubista E; Spona J
Gynakol Rundsch; 1989; 29 Suppl 2():400-1. PubMed ID: 2558992
[No Abstract] [Full Text] [Related]
7. [Significance of the proliferative activity of breast cancer for prognosis and therapy].
Pickartz H
Z Arztl Fortbild (Jena); 1991 Oct; 85(20):993-4. PubMed ID: 1776291
[No Abstract] [Full Text] [Related]
8. [The effect of transport conditions on biochemically and immunohistochemically determined steroid hormone receptor content in breast cancer].
Remmele W; Schicketanz KH
Pathologe; 1993 Jan; 14(1):21-4. PubMed ID: 8383846
[No Abstract] [Full Text] [Related]
9. [Steroid hormone receptor status and other immunohistochemical prognostic markers in benign and malignant diseases of the breast].
Nizze H; al-Thobhani AK; Terpe H
Zentralbl Chir; 1998; 123 Suppl 5():14-8. PubMed ID: 10063564
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of the receptor content and growth fraction of breast cancers and their axillary lymph node metastases].
Fleige B; Pickartz H; Stein H
Pathologe; 1989 Jan; 10(1):12-5. PubMed ID: 2646629
[No Abstract] [Full Text] [Related]
11. Correlation of steroid receptors in synchronous tissues with survival in breast cancer patients.
Bhatavdekar JM; Patel DD; Karelia NH; Suthar TP; Shah NG; Vora HH; Ghosh N; Nadkarni SP; Balar DB
Neoplasma; 1993; 40(3):177-80. PubMed ID: 8350965
[TBL] [Abstract][Full Text] [Related]
12. [Expression of cathepsin D in breast cancer and its clinical and histopathological correlations].
Ramírez-Ortega MC; Frías-Mendívil M; Delgado-Chávez R; Meneses-García A; Carrillo-Hernández JF; Ramírez-Ugalde MT; Zeichner-Gancz I
Rev Invest Clin; 1997; 49(5):361-8. PubMed ID: 9527695
[TBL] [Abstract][Full Text] [Related]
13. Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination.
Yu H; Levesque MA; Clark GM; Diamandis EP
Br J Cancer; 1999 Oct; 81(3):490-5. PubMed ID: 10507775
[TBL] [Abstract][Full Text] [Related]
14. Nonlinear discriminant analysis and prognostic factor classification in node-negative primary breast cancer using probabilistic neural networks.
Le Goff JM; Lavayssière L; Rouëssé J; Spyratos F
Anticancer Res; 2000; 20(3B):2213-8. PubMed ID: 10928180
[TBL] [Abstract][Full Text] [Related]
15. Molecular prognostic factors for breast cancer metastasis and survival.
Esteva FJ; Sahin AA; Cristofanilli M; Arun B; Hortobagyi GN
Semin Radiat Oncol; 2002 Oct; 12(4):319-28. PubMed ID: 12382190
[TBL] [Abstract][Full Text] [Related]
16. ["Prognostic factors" in breast cancer--1].
Brockmann B; Reitzig P
Z Arztl Fortbild (Jena); 1994 Feb; 88(2):111-4. PubMed ID: 8147017
[No Abstract] [Full Text] [Related]
17. High levels of messenger RNAs for tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in primary breast carcinomas are associated with development of distant metastases.
Ree AH; Florenes VA; Berg JP; Maelandsmo GM; Nesland JM; Fodstad O
Clin Cancer Res; 1997 Sep; 3(9):1623-8. PubMed ID: 9815852
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors for breast cancer and their use in the clinical setting.
Kapoor A; Vogel VG
Expert Rev Anticancer Ther; 2005 Apr; 5(2):269-81. PubMed ID: 15877524
[TBL] [Abstract][Full Text] [Related]
19. [Quantitative determination of steroid hormone receptors in breast cancer tissue outside tumor centers].
Prechtel D; Prechtel K
Pathologe; 1993 Jan; 14(1):16-20. PubMed ID: 8451222
[No Abstract] [Full Text] [Related]
20. [Therapeutic targeting in breast cancer].
Penault-Llorca F
Ann Pathol; 2009 Nov; 29 Spec No 1():S71-3. PubMed ID: 19887259
[No Abstract] [Full Text] [Related]
[Next] [New Search]
